Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CRISPR screens for synthetic rescue of cFLIP depletion in primary effusion lymphoma cell lines

ABSTRACT: CRISPR screens for synthetic rescue of cFLIP depletion in primary effusion lymphoma cell lines

PROVIDER: PRJNA865737 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20794981.fastq.gz	Fastqsanger.gz
	SRR20794982.fastq.gz	Fastqsanger.gz
	SRR20794983.fastq.gz	Fastqsanger.gz
	SRR20794984.fastq.gz	Fastqsanger.gz
	SRR20794985.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

CRISPR screens for synthetic rescue of cFLIP depletion in primary effusion lymphoma cell lines

Project description:Kaposi’s sarcoma-associated herpesvirus (KSHV) causes the B cell malignancy primary effusion lymphoma (PEL). We have previously shown that cultured PEL cell lines require expression of the cellular FLICE inhibitory protein (cFLIP) for survival (Manzano et al., Nat Comm 2018), although KSHV encodes a viral homolog of this protein (vFLIP). Here we employed genome-wide CRISPR/Cas9 synthetic rescue screens to identify loss of function perturbations that can compensate for cFLIP knockout/knockdown.

2022-08-10 | GSE210445 | GEO

Genome-wide CRISPR inactivation based resistance screens using IMiDs in Primary Effusion Lymphoma (PEL) cells

Project description:Genome-wide CRISPR inactivation based resistance screens using IMiDs in Primary Effusion Lymphoma (PEL) cells

| PRJNA503251 | ENA

Measuring gene expression profiles of E. coli synthetic rescue strains

Project description:This goal of these experiments is to assess steady-state transcript levels in a set of E. coli mutants (ppk, dgk, zwf, entC, and dapF null strains) that grow slowly in M9 glucose, and to compare these transcript levels to corresponding synthetic rescue strains (i.e. spontaneous suppressor strains in which slow growth is rescued to wild-type levels).

2017-09-06 | GSE85914 | GEO

Primary effusion lymphoma cell lines BC-1 and BC-3

Project description:Microarray analysis of primary effusion lymphoma cell lines BC-1 and BC-3

2011-11-16 | GSE31745 | GEO

CRISPR genome-wide synthetic lethality screens of KRAS-driven mouse pancreatic ductal adenocarcinoma cells

Project description:We performed CRISPR genome-wide synthetic lethality screens to identify genetic vulnerabilities and chemogenetic interactions in KRAS-driven pancreatic cancer. We identify ERAD as a genetic target that synergizes with FTS treatment and we show that FTS treatment induces ER stress, which was further enhanced by inhibition of ERAD, leading to synergistic induction of apoptosis in pancreatic tumor cells. Altogether, our screens enable us to identify combination therapies for cancer treatment.

2020-11-25 | GSE162065 | GEO

Genome-wide CRISPR inactivation based resistance screens using IMiDs in Primary Effusion Lymphoma (PEL) cells

Project description:We report the application of genome-wide CRISPR-Cas9 inactivation based screening technology to identify genes whose inactivation can confer resistance to the IMiD compounds Lenalidomide, Pomalidomide and Avadomide (CC-122) in Kaposi's sarcoma-associated herpesvirus-transformed primary effusion lymphoma cell line BC-3. Cas9 expressing BC-3 cells were transduced with a lentiviral genome-wide targeting sgRNA library (Brunello, Doench et al, Nature Biotechnology, 2016) and subsequently treated with lethal concentrations (5uM Lenalidomide, 1uM Pomalidomide and 1uM CC-122) of the IMiD compounds mentioned above or DMSO vehicle. gDNA from resistant cells and matched DMSO treated control cells was harvested and the lentiviral sgRNA inserts in each sample were PCR amplified, barcoded and subjected to next gen sequencing on the Illumina HiSeq 4000 platform. This study provides a candidate list of genes whose inactivation can confer resistance to one or more IMiD compounds in BC-3 cells.

2019-06-12 | GSE122040 | GEO

Affymetrix 500K SNP array data for Primary Effusion Lymphoma samples

Project description:Affymetrix 500K array was used to determine gross genomic aberrations in a panel of Primary Effusion Lymphoma (PEL) cell lines, specifically focusing on chromosome 10, which includes the Phosphatase and Tensin Homolog (PTEN) locus.

2011-06-23 | GSE28684 | GEO

Primary effusion lymphoma cell lines BC-1 and BC-3

Project description:Microarray analysis of primary effusion lymphoma cell lines BC-1 and BC-3 Total RNA from BC-1 and BC-3 cell lines was processed for analysis in one replicate on Human Gene 1.0 ST arrays to obtain data on whether genes are expressed and to compare to existing microarray data.

2011-11-16 | E-GEOD-31745 | biostudies-arrayexpress

circRNA-sequencing of a lymph node in a primary effusion lymphoma patient

Project description:Total RNA was extracted from a lymph node of a primary effusion lymphoma patient and treated with Rnase R to degrade linear, but not circular, RNA followed by deep-sequencing (PE150).

2021-06-30 | GSE165525 | GEO

Pleural effusion

Project description:Pleural effusion Raw sequence reads

| PRJNA692057 | ENA